Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Aquestive Therapeutics, Inc. (AQST)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16
   10-K10-K10-K10-K10-K10-KS-1/A
Revenues:  
    Proprietary product sales, net  7.78.55.6    
    Sunovion    11.9    
    Indivior    26.1    
    Other  40.042.32.1    
Total revenues  47.750.845.852.667.466.967.1
            Revenue growth   [+]-6.2%10.9%-12.8%-22.0%0.8%-0.3% 
Cost of goods sold  0.00.00.020.40.00.031.8
Gross profit  47.750.845.832.267.466.935.3
            Gross margin  100.0%100.0%100.0%61.3%100.0%100.0%52.6%
Selling, general and administrative  52.953.555.964.372.325.120.8
Research and development  17.517.019.920.623.122.1 
Other operating expenses  19.415.013.0 21.019.815.4
EBITDA   [+]-39.7-31.7-39.5-49.8-45.73.73.0
            EBITDA margin  -83.2%-62.4%-86.0%-94.6%-67.8%5.5%4.5%
Depreciation  2.32.93.42.93.23.83.8
EBITA  -42.0-34.6-42.8-52.6-48.9-0.1-0.8
            EBITA margin  -88.0%-68.1%-93.4%-100.0%-72.5%-0.1%-1.2%
Amortization of intangibles  0.10.10.10.10.10.10.1
EBIT   [+]-42.1-34.7-42.9-52.7-48.9-0.1-0.8
            EBIT margin  -88.2%-68.2%-93.6%-100.1%-72.6%-0.2%-1.3%
Interest expense, net   [+]6.610.011.18.77.77.7 
Other income (expense), net   [+]-5.8-25.8-1.8-4.9-4.7-1.1-8.8
Pre-tax income  -54.4-70.5-55.8-66.2-61.4-8.9-9.6
Income taxes  0.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -54.4-70.5-55.8-66.2-61.4-11.4-9.6
            Net margin  -114.1%-138.8%-121.7%-125.9%-91.0%-17.1%-14.3%
   
Basic EPS   [+]($1.12)($1.85)($1.66)($2.61)($2.96)  
Diluted EPS   [+]($1.12)($1.85)($1.66)($2.61)($2.96)  
   
Shares outstanding (basic)   [+]48.738.133.725.420.7  
Shares outstanding (diluted)   [+]48.738.133.725.420.7  
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy